Sources of Innovation of Drug Discovery in Japan and Its Implications
This final chapter analyzes the sources of innovation by exploiting the case studies as well as a complementary large scale survey on drug discovery projects in Japan in a unified framework, and discusses their potential implications on innovation management and policy. The focal issues of discussion are: (A) knowledge sources of the discovery projects; (B) the dynamic relationship between drug discovery and scientific progress; (C) coping with uncertainty; (D) uniqueness and competition in discovery; and (E) implications on management and policy. We hope that the discussion of these topics will deepen our understandings of pharmaceutical innovations.
- Itoh, M. (2006). Drug discovery story, Shinkoh_igaku (in Japanese).Google Scholar
- Itoh, H. (2015). Organizing for change: Preference diversity, effort incentives, and separation of decision and execution. RIETI Discussion Paper Series 15-E-082.Google Scholar
- Kirsch, D. B., & Ogas, O. (2017). The drug hunters. New York: Arcade Publishing.Google Scholar
- Koike, K. (1994). Employment system of Japan—Its universality and strengths. Toyo Keizai Shimbun, Inc. (In Japanese).Google Scholar
- Nagaoka, S., Nishimura, H., & Genda, K. (2015). Drug discovery and science-survey on the science origins of pharmaceutical innovation and their economic effects (1). IIR Working Paper 15-16, Institute of Innovation Research, Hitotsubashi University. (in Japanese).Google Scholar
- Zucker, G. Z., Darby, M. R., & Brewer, M. B. (1998). Intellectual human capital and the birth of US biotechnology enterprises. American Economic Review, 88(1), 290–306.Google Scholar